Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
US7115565B2 · kind B2 · utility
30Cited by
26References
61Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 14, 2002 |
| Grant date | Oct 3, 2006 |
| Priority date | — |
| Expiry date | Feb 10, 2022 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB82Y5/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions suitable for oral administration comprising paclitaxel, a solvent, a surfactant, a substituted cellulosic polymer, and optionally but preferably a P-glycoprotein inhibitor. The composition may further comprise a diglyceride or mixture of diglyceride and monoglyceride. The composition generates a supersaturated paclitaxel microemulsion upon contact with water resulting in improved oral bioavailability of paclitaxel.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.